View More Recent Stories

Jul 17, 2015 09:07PM
Jul 16, 2015 12:52PM
Jul 16, 2015 11:14AM
Jul 15, 2015 05:17PM
Jul 15, 2015 05:15PM
Jul 13, 2015 07:40AM
Jul 10, 2015 09:25AM Pre-Open Stock Movers 07/10: (ICLD) (CVC) (SYT) Higher; (CUDA) (HELE) (DOV) Lower (more...)
Jul 9, 2015 06:18PM
Jul 9, 2015 05:17PM
Jul 9, 2015 04:57PM
Jul 9, 2015 04:56PM
Jul 8, 2015 02:41PM
Jul 7, 2015 01:50PM
Jul 7, 2015 03:11AM Young Montana Man with Stage 4 Colon Cancer Shares Story of Pursuit for Personalized Cancer Treatment; Andrew Matney Travels Country with Hope of Saving Lives
Jul 6, 2015 11:42AM
Jul 6, 2015 10:40AM
Jul 1, 2015 01:45PM
Jun 30, 2015 04:32PM
Jun 29, 2015 11:05AM
Jun 29, 2015 11:05AM
Jun 29, 2015 11:00AM BioNano Mapping Technology Achieves Most Contiguous Clone-free Human Genome Assembly to Date
Jun 29, 2015 08:30AM
Jun 26, 2015 06:25PM
Jun 26, 2015 01:03AM
Jun 26, 2015 01:03AM
Jun 25, 2015 09:54AM
Jun 24, 2015 05:23PM
Jun 24, 2015 02:53PM New Prize Competition Hopes to Boost Discovery of Novel Breast Cancer Genetic Pathways
Jun 24, 2015 01:56PM
Jun 24, 2015 12:46PM
Jun 24, 2015 11:16AM
Jun 24, 2015 10:43AM
Jun 24, 2015 08:30AM
Jun 24, 2015 08:07AM
Jun 24, 2015 08:07AM Catyalyst Pharma (CPRX) Updates on Top-Line Data from CPP-109 Trial in TD; One of Four Patients Shows Clinically Significant Change
Jun 24, 2015 08:03AM
Jun 24, 2015 08:00AM
Jun 24, 2015 12:45AM
Jun 23, 2015 12:47PM
Jun 23, 2015 11:55AM
Jun 23, 2015 10:00AM
Jun 23, 2015 08:01AM Onconova to Host Myelodysplastic Syndromes (MDS) Key Opinion Leader Meeting on Tuesday, June 30 in New York City
Jun 19, 2015 12:14PM
Jun 19, 2015 11:45AM
Jun 19, 2015 11:20AM
Jun 18, 2015 11:50AM
Jun 16, 2015 03:00PM
Jun 15, 2015 08:02AM
Jun 15, 2015 08:01AM Onconova Presents Patient Selection Criteria and Intermediate Clinical Endpoints for Rigosertib in Higher-Risk Myelodysplastic Syndromes (HR-MDS) at EHA Annual Meeting
Jun 12, 2015 04:20PM
View More Recent Stories
6,439 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All